Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Olsson

Showing results (591-600 of 599) with videos related to

Pageof 60
Sort By:
You have reached the last page of results.This site can display upto 599 results.
The European Respiratory Journal|November 5, 2021
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertensionMarius M Hoeper, Christine Pausch, Karen M Olsson, et al.
Nature Communications|September 9, 2020
Integration of molecular profiles in a longitudinal wellness profiling cohortAbdellah Tebani, Anders Gummesson, Wen Zhong, et al.
Rheumatology (Oxford, England)|July 18, 2023
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysisOliver Distler, Christian Ofner, Dörte Huscher, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 5, 2025
International Society for Heart and Lung Transplantation (ISHLT) Consensus Statement on Risk Stratification in Pulmonary Arterial HypertensionSandeep Sahay, Scott Visovatti, Adriano R Tonelli, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 24, 2025
Authors' Perspective on the International Society for Heart and Lung Transplantation Consensus Statement on Risk Stratification in Pulmonary Arterial HypertensionSandeep Sahay, Scott Visovatti, Adriano R Tonelli, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 4, 2022
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysisStephan Rosenkranz, Christine Pausch, John G Coghlan, et al.
American Journal of Respiratory and Critical Care Medicine|August 7, 2025
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, et al.
The Lancet. Respiratory Medicine|July 1, 2022
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysisMarius M Hoeper, Krit Dwivedi, Christine Pausch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 21, 2020
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Pageof 60

Showing results (591-600 of 599) with videos related to

Sort By:
Pageof 60
You have reached the last page of results.This site can display upto 599 results.
The European Respiratory Journal|November 5, 2021
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertensionMarius M Hoeper, Christine Pausch, Karen M Olsson, et al.
Nature Communications|September 9, 2020
Integration of molecular profiles in a longitudinal wellness profiling cohortAbdellah Tebani, Anders Gummesson, Wen Zhong, et al.
Rheumatology (Oxford, England)|July 18, 2023
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysisOliver Distler, Christian Ofner, Dörte Huscher, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 5, 2025
International Society for Heart and Lung Transplantation (ISHLT) Consensus Statement on Risk Stratification in Pulmonary Arterial HypertensionSandeep Sahay, Scott Visovatti, Adriano R Tonelli, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 24, 2025
Authors' Perspective on the International Society for Heart and Lung Transplantation Consensus Statement on Risk Stratification in Pulmonary Arterial HypertensionSandeep Sahay, Scott Visovatti, Adriano R Tonelli, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 4, 2022
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysisStephan Rosenkranz, Christine Pausch, John G Coghlan, et al.
American Journal of Respiratory and Critical Care Medicine|August 7, 2025
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, et al.
The Lancet. Respiratory Medicine|July 1, 2022
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysisMarius M Hoeper, Krit Dwivedi, Christine Pausch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 21, 2020
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Pageof 60